Skinvisible, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.0K | $20.0K | $20.0K | $279.3K | $663.4K | $152.6K | $42.1K | $69.3K |
| Cost of Revenue | — | — | — | $4.8K | $3.3K | — | $17.6K | $20.7K |
| Gross Profit | $20.0K | $20.0K | $20.0K | $274.5K | $660.1K | $275.6K | $25.6K | $48.6K |
| Gross Margin | 100.0% | 100.0% | 100.0% | 98.3% | 99.5% | 180.5% | 60.9% | 70.1% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $496.1K | $589.2K | $491.6K | $494.2K | $454.1K | $497.2K | $525.8K | $607.6K |
| Operating Income | $-496.3K | $-589.6K | $-490.4K | $-238.4K | $188.1K | $-253.7K | $-539.8K | $-597.9K |
| Operating Margin | -2,481.6% | -2,947.9% | -2,451.9% | -85.4% | 28.3% | -166.2% | -1,283.2% | -862.2% |
| Interest Expense | $572.2K | $669.4K | $1.9M | $1.2M | $1.2M | $1.2M | $1.0M | $1.0M |
| Pretax Income | — | — | — | — | — | $-1.4M | $-1.7M | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-1.1M | $-565.7K | $-2.4M | $-1.2M | $-1.1M | $-1.4M | $-1.7M | $158.3K |
| Net Margin | -5,320.2% | -2,828.3% | -11,912.2% | -438.6% | -161.7% | -948.4% | -4,046.3% | 228.3% |
| EPS (Basic) | $-0.20 | $-0.11 | $-0.52 | $-0.27 | $-0.24 | $-0.32 | $-0.59 | $0.01 |
| EPS (Diluted) | — | $-0.11 | $-0.52 | $-0.27 | $-0.24 | $-0.32 | $-0.59 | $0.01 |
| Shares Outstanding (Basic) | 5.4M | 5.1M | 4.5M | 4.5M | 4.5M | 4.5M | 2.9M | 2.9M |
| Shares Outstanding (Diluted) | 5.4M | 5.1M | 4.5M | 4.5M | 4.5M | 4.5M | 2.9M | 30.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |